The value, speed of completion and robustness of the evidence generated by TB treatment clinical trials could be improved by implementing standards for best practice.
A paper, published in the International Journal of Tuberculosis and Lung Disease (IJTLD), presents 11 standards for TB treatment clinical trials approved by a global panel of experts with >90% consensus achieved for all standards.
Access the full publication here.